Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness
In November 2017, it was announced that the new dengue vaccine (“Dengvaxia”) had risks for those not previously exposed to dengue. While some countries proceeded with adjusting guidance accordingly, the Philippines reacted with outrage and political turmoil with naming and shaming of government offi...
Main Authors: | Heidi J Larson, Kenneth Hartigan-Go, Alexandre de Figueiredo |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-03-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2018.1522468 |
Similar Items
-
Perceptions of dengue risk and acceptability of a dengue vaccine in residents of Puerto Rico
by: Coral Rosado-Santiago, et al.
Published: (2024-12-01) -
Vaccine confidence in China after the Changsheng vaccine incident: a cross-sectional study
by: Baohua Liu, et al.
Published: (2019-11-01) -
Recent trends in vaccine coverage and confidence: A cause for concern
by: Rachel L. Eagan, et al.
Published: (2023-08-01) -
Regarding response by Dans et. al. to our article, “Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness.”
by: Heidi Larson, et al.
Published: (2019-03-01) -
Identification of prior dengue-naïve Dengvaxia recipients with an increased risk for symptomatic dengue during fever surveillance in the Philippines
by: Yu-Ching Dai, et al.
Published: (2023-07-01)